Phase I Study to Evaluate the Safety and Immunogenicity of HIV-1 Immunogen in Children With HIV-1 Infection
PHASE1CompletedINTERVENTIONAL
Enrollment
32
Participants
Timeline
Start Date
August 31, 1995
Study Completion Date
July 31, 2001
Conditions
HIV Infection
Interventions
BIOLOGICAL
HIV-1 Immunogen
Trial Locations (1)
20892
National Cancer Institute (NCI), Bethesda
All Listed Sponsors
lead
National Cancer Institute (NCI)
NIH
NCT00001445 - Phase I Study to Evaluate the Safety and Immunogenicity of HIV-1 Immunogen in Children With HIV-1 Infection | Biotech Hunter | Biotech Hunter